Host and viral factors affecting the decreased immunogenicity of Sabin type 3 vaccine after administration of trivalent oral polio vaccine to rural Mayan children

Journal of Infectious Diseases

Volumn 175, Issue 3, 1997, Pages 545-553

  Maldonado, Yvonne A ^a   Peña Cruz, Victor ^b   De La Sanchez, Maria Luz ^e   Logan, Linda ^e   Blandón, Stewart ^e   Cantwell, Michael F ^e   Matsui, Suzanne M ^e   Millan Velasco, Francisco ^c   Valdespino, Jose Luis ^d   Sepulveda, Jaime ^d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Regional Hospital   (Mexico)

^d INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE; TRIPLE VACCINE; VIRUS ANTIBODY;

ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; IMMUNOGENICITY; IMMUNOREACTIVITY; INFANT; MAJOR CLINICAL STUDY; POLIOMYELITIS; PRIORITY JOURNAL; VACCINATION;

EID: 16944365653     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/175.3.545     Document Type: Article

References (19)

1. Wright PF, Kim-Farley RJ, de Quadros CA, et al. Strategies for the global eradication of poliomyelitis by the year 2000. N Engl J Med 1991;325:1774-9.
2. Centers for Disease Control and Prevention. Certification of poliomyelitis eradication - the Americas, 1994. MMWR Morb Mortal Wkly Rep 1994;43:720-2.
3. Mulders MN, Lipskaya GY, van der Avoort HGAM, Koopmans MPG, Kew OM, van Loon AM. Molecular epidemiology of wild poliovirus type 1 in Europe, the Middle East, and the Indian subcontinent. J Infect Dis 1995;171:1399-405.
4. Bottiger M, Herrstrom E. Isolation of polioviruses from sewage and their characteristics: experience over two decades in Sweden. Scand J Infect Dis 1992;24:151-5.
5. Oostvogel PM, van Wijngaarden JK, van der Avoort HG, et al. Poliomyelitis outbreak in an unvaccinated community in the Netherlands, 1992-93. Lancet 1994;344:665-70.
6. Pangi NS, Master JM, Dave KH. Efficacy of oral polio vaccine in infancy. Indian Pediatr 1977;14:523-8.
7. Domok I, Balayan MS, Fayinka OA, Skrtic N, Soneji AD, Harland PS. Factors affecting the efficacy of live poliovirus vaccines in warm climates. Efficacy of type 1 Sabin vaccine administered together with antihuman gamma globulin horse serum to breast-fed and artifically fed infants in Uganda. Bull World Health Organ 1974;51:333-47.
8. Sangkawibha N, Tuchinda P, Bukkavesa S, Tuchinda M. Antibody response and virus excretion after oral vaccination with trivalent live poliomyelitis vaccine. J Med Assoc Thailand 1969;52:701-12.
9. Ghosh S, Kumari S, Balaya S, Bhargava SK. Antibody response to oral polio vaccine in infancy. Indian Pediatr 1970;7:78-81.
10. John TJ, Christopher S. Oral polio vaccination of children in the tropics. III. Intercurrent enterovirus infections, vaccine virus take and antibody response. Am J Epidemiol 1975;102:422-8.
11. John TJ, Jayabal P. Oral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interference. Am J Epidemiol 1972;96:263-9.
12. John TJ. Problems with oral poliovaccine in India. Indian Pediatr 1972;9:252-6.
13. Swartz TA, Skalska P, Gerichter CG, Cockburn WC. Routine administration of oral polio vaccine in a subtropical area. Factors possibly influencing seroconversion rates. J Hyg Cambridge 1972;70:719-26.
14. Montefiore DG. Problems of poliomyelitis immunization in countries with warm climates. In: Proceedings of the International Conference on the Application of Vaccines against Viral, Rickettsial, And Bacterial Diseases of Man. Washington, DC: Pan American Health Organization, 1971:182-5; scientific publication 226.
15. Silliker JH, Gabis DA. Salmonellosis. In: Balows A, Hausler WJ Jr, Ohashi M, Turano A, eds. Laboratory diagnosis of infectious diseases. Principles and practice. Vol I. New York: Springer-Verlag, 1988:448-65.
16. Watanabe H. Shigellosis. In: Balows A, Hausler WJ Jr, Ohashi M, Turano A, eds. Laboratory diagnosis of infectious diseases. Principles and practice. Vol 1. New York: Springer-Verlag, 1988:466-72.
17. Moyer NP, Holcomb LA. Campylobacteriosis. In: Balows A, Hausler WJ Jr, Ohashi M, Turano A, eds. Laboratory diagnosis of infectious diseases. Principles and practice. Vol 1. New York: Springer-Verlag, 1988: 155-67.
18. Pan American Health Organization. Microneutralization test for poliovirus antibodies. In: Procedural guide for polioviruses and enteroviruses. Washington, DC: Pan American Health Organization 1988:22-4.
19. Wood DJ, Heath AB. The second international standard for anti-poliovirus sera types 1, 2, and 3. Biologicals 1992;30:203-11.